
The Immunocytokine F8-IL2 Improves the Therapeutic Performance of Sunitinib in a Mouse Model of Renal Cell Carcinoma
Keywords: extracellular matrix proteins; carcinoma; renal cell; cytokines; F8 monoclonal antibody; sunitinib; EDA; extradomain-A of fibronectin; hu; human; IFN; interferon; IL2; interleukin-2; NIBSC; National Institute for Biological Standards and Control; NK; natu